OXYGENTA PHARMACEUTICAL
Back to All Ratios
|
OXYGENTA PHARMACEUTICAL Last 5 Year Profit After Tax (PAT) Margin History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| PAT Margin (%) | -15.55 | -9.42 | -8.78 | -37.34 | -1.01 |
What is the latest Profit After Tax (PAT) Margin ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Profit After Tax (PAT) Margin |
|---|---|
| Mar2026 | -15.55 |
| Mar2025 | -9.42 |
| Mar2024 | -8.78 |
| Mar2023 | -37.34 |
| Mar2022 | -1.01 |
How is Profit After Tax (PAT) Margin of OXYGENTA PHARMACEUTICAL Trending?
| Years | Profit After Tax (PAT) Margin | % Change | |
|---|---|---|---|
| Mar2026 | -15.55 | Negative | |
| Mar2025 | -9.42 | Negative | |
| Mar2024 | -8.78 | Negative | |
| Mar2023 | -37.34 | Negative | |
| Mar2022 | -1.01 | - | |
Other Financial Ratios of OXYGENTA PHARMACEUTICAL
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Profit After Tax (PAT) Margin ratio of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹177.6 Cr | -2% | -8.6% | -25.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,780.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,828.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹109,305.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,759.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -2% |
-8.6% |
-25.2% |
| SENSEX | -1.5% |
-1.2% |
-11.8% |
You may also like the below Video Courses